Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 60

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Increased Cerebrospinal Fluid Levels of Double-Stranded RNA-Dependant Protein Kinase in Alzheimer's Disease

Mouton-Liger, François, Paquet, Claire, Dumurgier, Julien, Lapalus, Pauline, Gray, Françoise, Laplanche, Jean-Louis, Hugon, Jacques · 2012 · Biological Psychiatry

Abstract

Background The pathological hallmarks of Alzheimer's disease (AD) include accumulation of amyloid-β (Aß) peptide forming extracellular senile plaques, neurofibrillary tangles made of hyperphosphorylated tau protein with neuronal loss. Aβ peptide (1-42), total tau (T-tau), and phosphorylated tau at threonine 181 (p181tau) levels in the cerebrospinal fluid (CSF) are now validated biomarkers. The proapoptotic kinase R (PKR), is activated by Aβ accumulates in degenerating neurons in AD brains and controls protein synthesis and indirectly tau phosphorylation. Methods In a prospective cohort study, the CSF of 91 patients were studied (AD: 45; amnestic mild cognitive impairment: 11; neurological disease control subjects [NDC]: 35). The levels of total PKR (T-PKR), phosphorylated PKR (pPKR), Aß 1-42, T-tau, and p181tau were assessed by immunoblotting or enzyme-linked immunosorbent assay methods. Receivers operating characteristic curves were used to examine the discriminatory power of T-PKR, pPKR, and pPKR/T-PKR ratio between AD and NDC patients. Results Total PKR and pPKR concentrations were elevated in AD and amnestic mild cognitive impairment subjects. We have determined a pPKR value (optical density units) that could discriminate AD patients from control subjects with a sensitivity of 91.1% and a specificity of 94.3%. Among AD patients, T-PKR and pPKR levels correlate with CSF p181tau levels. Some AD patients with normal CSF Aß, T-tau, or p181tau levels had abnormal T-PKR and pPK…

Overview

Integrity signals

Registry

Crossref · 10.1016/j.biopsych.2011.11.031

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 11 references

Research works printed but not linked: 27

  1. Rossor, 2010, The diagnosis of young-onset dementia, Lancet Neurol, 9, 793, 10.1016/S1474-4422(10)70159-9 · DOI · Paper page
  2. Duyckaerts, 2009, Classification and basic pathology of Alzheimer disease, Acta Neuropathol, 118, 5, 10.1007/s00401-009-0532-1 · DOI · Paper page
  3. Petersen, 2001, Current concepts in mild cognitive impairment, Arch Neurol, 58, 1985, 10.1001/archneur.58.12.1985 · DOI · Paper page
  4. Hardy, 2002, The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics, Science, 297, 353, 10.1126/science.1072994 · DOI · Paper page
  5. Steele, 2011, Apomorphine and Alzheimer Aβ: Roles for regulated α cleavage, autophagy, and antioxidation?, Ann Neurol, 69, 221, 10.1002/ana.22359 · DOI
  6. Dubois, 2007, Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria, Lancet Neurol, 6, 734, 10.1016/S1474-4422(07)70178-3 · DOI · Paper page
  7. McKhann, 2011, The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimers Dement, 7, 263, 10.1016/j.jalz.2011.03.005 · DOI · Paper page
  8. Dumurgier, 2010, Inverse association between CSF Abeta 42 levels and years of education in mild form of Alzheimer's disease: The cognitive reserve theory, Neurobiol Dis, 40, 456, 10.1016/j.nbd.2010.07.007 · DOI
  9. Hotamisligil, 2010, Endoplasmic reticulum stress and the inflammatory basis of metabolic disease, Cell, 140, 900, 10.1016/j.cell.2010.02.034 · DOI · Paper page
  10. Nakamura, 2010, Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis, Cell, 140, 338, 10.1016/j.cell.2010.01.001 · DOI · Paper page
  11. Paquet, 2011, The PKR activator PACT is induced by Aβ: Involvement in Alzheimer's disease, Brain Pathol
  12. Page, 2006, Activated double-stranded RNA-dependent protein kinase and neuronal death in models of Alzheimer's disease, Neuroscience, 139, 1343, 10.1016/j.neuroscience.2006.01.047 · DOI · Paper page
  13. Onuki, 2004, An RNA-dependent protein kinase is involved in tunicamycin-induced apoptosis and Alzheimer's disease, EMBO J, 23, 959, 10.1038/sj.emboj.7600049 · DOI · Paper page
  14. Bose, 2011, Modulation of tau phosphorylation by the kinase PKR: Implications in Alzheimer's disease, Brain Pathol, 21, 189, 10.1111/j.1750-3639.2010.00437.x · DOI
  15. Ill-Raga, 2011, Activation of PKR causes amyloid ss-peptide accumulation via de-repression of BACE1 expression, PLoS One, 6, e21456, 10.1371/journal.pone.0021456 · DOI
  16. McKhann, 1984, Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology, 34, 939, 10.1212/WNL.34.7.939 · DOI · Paper page
  17. Paquet, 2009, Neuronal phosphorylated RNA-dependent protein kinase in Creutzfeldt-Jakob disease, J Neuropathol Exp Neurol, 68, 190, 10.1097/NEN.0b013e318196cd7c · DOI
  18. DeLong, 1988, Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach, Biometrics, 44, 837, 10.2307/2531595 · DOI · Paper page
  19. Yeung, 1996, An essential role for the interferon-inducible, double-stranded RNA-activated protein kinase PKR in the tumor necrosis factor-induced apoptosis in U937 cells, Proc Natl Acad Sci U S A, 93, 12451, 10.1073/pnas.93.22.12451 · DOI · Paper page
  20. Ballard, 2011, Alzheimer's disease, Lancet, 377, 1019, 10.1016/S0140-6736(10)61349-9 · DOI · Paper page
  21. Querfurth, 2010, Alzheimer's disease, N Engl J Med, 362, 329, 10.1056/NEJMra0909142 · DOI · Paper page
  22. Zotova, 2010, Inflammation in Alzheimer's disease: Relevance to pathogenesis and therapy, Alzheimers Res Ther, 2, 1, 10.1186/alzrt24 · DOI · Paper page
  23. Kim, 2010, Activation of eukaryotic initiation factor-2 alpha-kinases in okadaic acid-treated neurons, Neuroscience, 169, 1831, 10.1016/j.neuroscience.2010.06.016 · DOI
  24. Bando, 2005, Double-strand RNA dependent protein kinase (PKR) is involved in the extrastriatal degeneration in Parkinson's disease and Huntington's disease, Neurochem Int, 46, 11, 10.1016/j.neuint.2004.07.005 · DOI · Paper page
  25. Peel, 2001, Double-stranded RNA-dependent protein kinase, PKR, binds preferentially to Huntington's disease (HD) transcripts and is activated in HD tissue, Hum Mol Genet, 10, 1531, 10.1093/hmg/10.15.1531 · DOI · Paper page
  26. Paccalin, 2006, Activated mTOR and PKR kinases in lymphocytes correlate with memory and cognitive decline in Alzheimer's disease, Dement Geriatr Cogn Disord, 22, 320, 10.1159/000095562 · DOI · Paper page
  27. Hugon, 2009, Could PKR inhibition modulate human neurodegeneration?, Expert Rev Neurother, 9, 1455, 10.1586/ern.09.92 · DOI

Cited by

See all 60

Metadata

Authors
Mouton-Liger, F., Paquet, C., Dumurgier, J., Lapalus, P., Gray, F., Laplanche, J.-L., & Hugon, J.
Venue
Biological Psychiatry
Publisher
Elsevier BV
Published
2012-05
Volume
71
Issue
9
Pages
829-835
ISSN
0006-3223
Cited by
60
References
11
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Increased Cerebrospinal Fluid Levels of Double-Stranded RNA-Dependant Protein Kinase in Alzheimer's Disease. https://app.cochat.ai/papers/10.1016/j.biopsych.2011.11.031
The paper
Mouton-Liger, F., Paquet, C., Dumurgier, J., Lapalus, P., Gray, F., Laplanche, J.-L., & Hugon, J. (2012). Increased Cerebrospinal Fluid Levels of Double-Stranded RNA-Dependant Protein Kinase in Alzheimer's Disease. Biological Psychiatry. https://doi.org/10.1016/j.biopsych.2011.11.031

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.